MusclePharm Corp, a leading name in the sports nutrition industry, is headquartered in the United States. Founded in 2010, the company has rapidly established itself as a key player in the market, focusing on innovative dietary supplements designed for athletes and fitness enthusiasts. With a diverse product range that includes protein powders, pre-workout formulas, and recovery aids, MusclePharm distinguishes itself through its commitment to quality and scientific research. The company operates primarily in North America but has expanded its reach globally, catering to a growing customer base. Notable achievements include partnerships with professional athletes and teams, which enhance its credibility and market presence. MusclePharm's dedication to performance-driven products and its emphasis on transparency have solidified its position as a trusted brand in the competitive landscape of sports nutrition.
How does MusclePharm Corp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MusclePharm Corp's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MusclePharm Corp, headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi). In the absence of concrete emissions data, it is important to note that MusclePharm Corporation has not publicly outlined any climate pledges or initiatives aimed at reducing its carbon footprint. This lack of information suggests that the company may not yet be actively engaged in formal climate commitments or sustainability strategies. As the industry increasingly prioritises climate action, MusclePharm Corp's current position highlights a potential area for growth in environmental responsibility and transparency.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MusclePharm Corp has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
